IL155801A0 - A nucleic acid sequence encoding human testis specific kinases - Google Patents

A nucleic acid sequence encoding human testis specific kinases

Info

Publication number
IL155801A0
IL155801A0 IL15580101A IL15580101A IL155801A0 IL 155801 A0 IL155801 A0 IL 155801A0 IL 15580101 A IL15580101 A IL 15580101A IL 15580101 A IL15580101 A IL 15580101A IL 155801 A0 IL155801 A0 IL 155801A0
Authority
IL
Israel
Prior art keywords
kinases
nucleic acid
acid sequence
sequence encoding
encoding human
Prior art date
Application number
IL15580101A
Other languages
English (en)
Original Assignee
Univ Virginia
Gregory S Kopf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Virginia, Gregory S Kopf filed Critical Univ Virginia
Publication of IL155801A0 publication Critical patent/IL155801A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Analytical Chemistry (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15580101A 2000-11-09 2001-11-09 A nucleic acid sequence encoding human testis specific kinases IL155801A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24693900P 2000-11-09 2000-11-09
US26492101P 2001-01-30 2001-01-30
PCT/US2001/046803 WO2002038732A2 (en) 2000-11-09 2001-11-09 Human testis specific serine/threonine kinase

Publications (1)

Publication Number Publication Date
IL155801A0 true IL155801A0 (en) 2003-12-23

Family

ID=26938336

Family Applications (4)

Application Number Title Priority Date Filing Date
IL15580101A IL155801A0 (en) 2000-11-09 2001-11-09 A nucleic acid sequence encoding human testis specific kinases
IL15580001A IL155800A0 (en) 2000-11-09 2001-11-09 Nucleic acid sequences encoding human testis specific kinases
IL155801A IL155801A (en) 2000-11-09 2003-05-08 Nucleic acid sequence encoding human testis specific kinases
IL155800A IL155800A (en) 2000-11-09 2003-05-08 Nucleic acid sequences encoding human testis specific kinases

Family Applications After (3)

Application Number Title Priority Date Filing Date
IL15580001A IL155800A0 (en) 2000-11-09 2001-11-09 Nucleic acid sequences encoding human testis specific kinases
IL155801A IL155801A (en) 2000-11-09 2003-05-08 Nucleic acid sequence encoding human testis specific kinases
IL155800A IL155800A (en) 2000-11-09 2003-05-08 Nucleic acid sequences encoding human testis specific kinases

Country Status (8)

Country Link
US (2) US7129057B2 (enExample)
EP (1) EP1339866B1 (enExample)
JP (5) JP2004513631A (enExample)
AT (2) ATE479771T1 (enExample)
AU (4) AU3769902A (enExample)
DE (2) DE60142804D1 (enExample)
IL (4) IL155801A0 (enExample)
WO (1) WO2002038732A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030108933A1 (en) * 2000-05-12 2003-06-12 Burkhard Scharm Novel serine-threonine kinase-3
US20050032146A1 (en) * 2003-08-07 2005-02-10 Herr John C. Tssk4: a human testis specific serine/threonine kinase
JP2008515797A (ja) * 2004-09-30 2008-05-15 ユニバーシティ オブ バージニア パテント ファウンデーション オスの避妊標的物としてのtsskファミリーメンバーおよびtsksの評価
JP2008067649A (ja) * 2006-09-14 2008-03-27 Osaka Univ 妊孕性診断キット、変異検出方法、ポリヌクレオチド、及びポリペプチド
CN115976033B (zh) * 2022-12-14 2024-05-17 西南大学 瓜实蝇tssk1和tssk3基因及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5173400A (en) * 1999-05-28 2000-12-18 Sugen, Inc. Protein kinases
AU2292301A (en) * 1999-12-23 2001-07-03 Incyte Genomics, Inc. Human kinases
US20040048249A1 (en) * 2000-01-21 2004-03-11 Tang Y. Tom Novel nucleic acids and secreted polypeptides
AU2001234944A1 (en) * 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
EP1278866A2 (en) * 2000-05-05 2003-01-29 MERCK PATENT GmbH Serine-threonine kinase
US6482935B1 (en) * 2000-05-24 2002-11-19 Applera Corporation Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
WO2002068649A2 (en) * 2001-01-31 2002-09-06 Curagen Corporation Proteins and nucleic acids encoding same
US20030211093A1 (en) * 2001-07-20 2003-11-13 Henry Yue Human kinases

Also Published As

Publication number Publication date
JP2004135653A (ja) 2004-05-13
AU3769902A (en) 2002-05-21
JP2004513631A (ja) 2004-05-13
US20030211563A1 (en) 2003-11-13
JP2010029197A (ja) 2010-02-12
EP1339866A4 (en) 2006-10-25
US20040030112A1 (en) 2004-02-12
IL155801A (en) 2009-12-24
AU2006202059A2 (en) 2006-06-15
JP2007306930A (ja) 2007-11-29
DE60142804D1 (de) 2010-09-23
DE60142984D1 (de) 2010-10-14
US6946275B2 (en) 2005-09-20
AU2002237699B2 (en) 2006-05-25
EP1339866A2 (en) 2003-09-03
ATE479771T1 (de) 2010-09-15
AU2002237699B9 (en) 2006-06-29
IL155800A (en) 2009-09-01
JP2009148281A (ja) 2009-07-09
WO2002038732A3 (en) 2002-12-05
ATE477332T1 (de) 2010-08-15
IL155800A0 (en) 2003-12-23
WO2002038732A2 (en) 2002-05-16
AU2006202059B2 (en) 2009-01-08
AU2006202059C1 (en) 2009-06-11
AU2006202059A1 (en) 2006-06-15
EP1339866B1 (en) 2010-09-01
US7129057B2 (en) 2006-10-31
AU2003204266B2 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
WO2000073469A3 (en) Protein kinases
WO2000043373A3 (en) Kinase inhibitors
CA2400447A1 (en) Kinase inhibitors
NO20053144L (no) Chk-, Pdk- og Akt-inhibitorpyrimidiner, deres fremstilling og anvendelse som famasoytiske midler.
IL173348A0 (en) Thienopyridine and furopyridine kinase inhibitors
WO2001044247A3 (en) Agents and methods for the treatment of proliferative diseases
MY145332A (en) Trisubstituted 4-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors
WO2003073999A3 (en) Pini-modulating compounds and methods of use thereof
WO2002026757A3 (en) Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes
GB0004128D0 (en) Novel compounds
NO20030381L (no) Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser
WO2003074550A3 (en) Pin1-modulating compounds and methods of use thereof
WO2003031606A3 (en) Crystal structure of an aurora kinase catalytic domain, and use thereof
MXPA02011425A (es) Derivados sustituidos de pirrolopiridinona utiles como inhibidores de fosfodiesterasa.
WO2001047543A3 (en) Activation and inhibition of the immune system
WO2002030353A3 (en) NF-λB INHIBITORS
NZ514576A (en) Substituted 3-cyano-[1.7], [1.5], and [1.8]- naphthyridine inhibitors of tyrosine kinases
AU2001232556A1 (en) Pyrimidine compounds and their use as modulators of chemokine receptor activity
WO2002053104A3 (en) Use of catecholamine reuptake inhibitors to enhance memory
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
IL155800A0 (en) Nucleic acid sequences encoding human testis specific kinases
MXPA04005809A (es) Inhibidores de proteinas quinasas.
IL149416A0 (en) Human enzymes of the metalloprotease family
WO2003034985A3 (en) Telomerase interference